Patent 6299868 Issued on October 9, 2001. Estimated Expiration Date: July 14, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
The present invention relates to a method for treating obesity, a method for reducing the absorption of dietary fat, and a method for treating hypertriglyceridemia in a patient and to particular polymers for use in the methods or in a manufacture of a medicament. The methods comprise the step of orally administering to a mammal, such as a human, a therapeutically effective amount of one or more fat-binding polymers. The administration of the fat-binding polymer of the invention facilitates the removal of fat from the body prior to digestion, with minimal side effects and low toxicity. In a preferred embodiment, the one or more fat-binding polymers are administered in combination with one or more lipase inhibitors, for example, lipstatin and tetrahydrolipstatin.
Other References
Sjostrom, L. et al., "Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients," The Lancet, GB, Lancet Limited, 352(9123) :167-172 (1998)
Gargouri, Y., et al., "Ajoene prevents fat digestion by human gastric lipase in vitro," Biochemica et Biophysica Acta. 1006:137-139 (1989)
Gargouri, Y., et al., "Covalent inhibition of digestive lipases: an in vitro study," Biochimica et Biophysica Acta. 1344:6-37 (1997)
Karamac, M. and Amarowicz, R., "Inhibition of Pancreatic Lipase by Phenolic Acids, Examination in vitro," Verlag der Zeitschrift fur Naturforschung:903-905 (1996)
Vainio, P., et al., "Inhibition of Lippoprotein Lipase by Benzene Boronic Acid Effect of Apolipoprotein C-II," Biochimica et Biophysica Acta. 711:386-390 (1982)
Bagree, A., et al., "Modification of .di-elect cons.-Amino Group of Lysine in Proteins by Acylation with Pyromellitic Dianhydride and 0-Sulphobenzoic Anhydride," FEBS Letters 120(2):275-277 (1980)
Stadler, P., et al., "Inhibition of microbial lipases with stereoisomeric triradylglycerol analog phosphonates," Biochimica et Biophysica Acta. 1304:229-244 (1996)
Kawaguchi, K., et al. "Hesperidin as an Inhibitor of Lipases from Procine Pancreas and Pseudomonas," Biosci. Biotech. Biochem. 61(1):102-104 (1997)
Bochenek, W.J. and Rodgers, J.B., "Effect of Polyol Detergents on Cholesterol and Triglyceride Absorption," Biochimica et Biophysica Acta 489:503-506 (1977)
Comai, K. and Sullivan, A.C., "Antiobesity activity of pluronic L-101," International Journal of Obesity 4:33-42 (1980)
Marguet, F., et al., "Digestive lipases: inactivation by phosphonates," Biochimica et Biophysica Acta. 1210:157-166 (1994)
Mannesse, M.L.M., et al., "Phosphonate analogues of triacylglycerols are potent inhibitor of lipase," Biochimica et Biophysica Acta. 1259:56-64 (1995)
Martichonok, V. and Jones, J.B., "(Z)-Heptadec-8-enylboronic acid: a potential lipase inhibitor," J. Chem. Soc. Perkin Trans. I:2927-2929 (1995)
Han, L-K, et al., "Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet," International Journal of Obesity 23:174-179 (1999)
Atkinson, et al., "Combined drug treatment of obesity," Obesity Research, vol. 3, No. S4:497S-500S (1995
July 14, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
